Cognitive Rehabilitation for Cancer Survivors with Perceived Cognitive Impairment

The University of Sydney0 个研究点目标入组 65 人开始时间: 2012年9月28日最近更新: 2022年4月19日

试验速览

暂无简介。

•1Diagnosis of invasive solid tumour cancer for which definitive treatment was performed within the last 5 years
•2Completed at least 3 cycles of chemotherapy
•3Aged >17 years
•4A NO” response recorded for the Single Item Cognitive Impairment Question
•5Speak fluent English and read to a year 8 standard.
•6Give written informed consent.
•7Chemotherapy, radiotherapy, immunotherapy (e.g. trastuzumab and/or lapatinib) received must have been completed at least 6 months prior to randomisation.
•8Hormonal treatment (including tamoxifen or an aromatase inhibitor) is permitted as long as treatment has been commenced at least 4 weeks prior to randomisation and is not likely to be ceased within 6 months of randomisation.

•1, ECOG Performance Status of > 2
•2, Any evidence of extra-nodal metastatic disease.
•3, Any major pre-existing neurological condition, co-morbidity, psychiatric history or substance abuse that could interfere with their ability to perform cognitive testing.
•4, Prior malignancy within the last 5 years (other than non-melanomatous skin cancer or cervical cancer in-situ) or previous chemotherapy other than adjuvant or neoadjuvant breast cancer treatment.

发起方